AK Medical's (HKG:1789) board approved an increase in the budget for on-market share repurchases to HK$500 million from HK$150 million, according to a Monday Hong Kong bourse filing.
The company plans to repurchase shares through June 17 under an existing mandate that allows it to buy back up to 112.3 million shares, or 10% of its issued share capital as of the 2025 annual general meeting.
AK Medical said it intends to hold repurchased shares as treasury shares rather than cancel them.